Cargando…
Angiopoietin-like protein 4 (ANGPTL4) is an inhibitor of endothelial lipase (EL) while the ANGPTL4/8 complex has reduced EL-inhibitory activity
We previously demonstrated that angiopoietin-like protein 8 (ANGPTL8) forms ANGPTL3/8 and ANGPTL4/8 complexes that increase with feeding to direct fatty acids (FA) toward adipose tissue through differential modulation of lipoprotein lipase (LPL) activity. Each complex correlated inversely with high...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417300/ https://www.ncbi.nlm.nih.gov/pubmed/34504977 http://dx.doi.org/10.1016/j.heliyon.2021.e07898 |
_version_ | 1783748349739925504 |
---|---|
author | Chen, Yan Q. Pottanat, Thomas G. Siegel, Robert W. Ehsani, Mariam Qian, Yue-Wei Konrad, Robert J. |
author_facet | Chen, Yan Q. Pottanat, Thomas G. Siegel, Robert W. Ehsani, Mariam Qian, Yue-Wei Konrad, Robert J. |
author_sort | Chen, Yan Q. |
collection | PubMed |
description | We previously demonstrated that angiopoietin-like protein 8 (ANGPTL8) forms ANGPTL3/8 and ANGPTL4/8 complexes that increase with feeding to direct fatty acids (FA) toward adipose tissue through differential modulation of lipoprotein lipase (LPL) activity. Each complex correlated inversely with high density lipoprotein cholesterol (HDL) in control subjects. We thus investigated ANGPTL3/8 and ANGPTL4/8 levels in type 2 diabetes patients, who can present with decreased HDL. While ANGPTL3/8 levels in type 2 diabetes patients were similar to those previously observed in normal controls, ANGPTL4/8 levels were roughly twice as high as those in control subjects. Concentrations of ANGPTL3/8 and ANGPTL4/8 in type 2 diabetes patients were inversely correlated with HDL, with the correlation being significant for ANGPTL4/8. We therefore measured the ability of the various ANGPTL proteins and complexes to inhibit endothelial lipase (EL), the enzyme which hydrolyzes phospholipids (PL) in HDL. While confirming ANGPTL3 as an EL inhibitor, we found that ANGPTL4 was a more potent EL inhibitor than ANGPTL3. Interestingly, we observed that while ANGPTL3/8 had increased EL-inhibitory activity compared to ANGPTL3 alone, ANGPTL4/8 exhibited decreased potency in inhibiting EL compared to ANGPTL4 alone. Together, these results show for the first time that ANGPTL4 is a more potent EL inhibitor than ANGPTL3 and suggest a possible reason for why ANGPTL4/8 levels are correlated inversely with HDL. |
format | Online Article Text |
id | pubmed-8417300 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-84173002021-09-08 Angiopoietin-like protein 4 (ANGPTL4) is an inhibitor of endothelial lipase (EL) while the ANGPTL4/8 complex has reduced EL-inhibitory activity Chen, Yan Q. Pottanat, Thomas G. Siegel, Robert W. Ehsani, Mariam Qian, Yue-Wei Konrad, Robert J. Heliyon Research Article We previously demonstrated that angiopoietin-like protein 8 (ANGPTL8) forms ANGPTL3/8 and ANGPTL4/8 complexes that increase with feeding to direct fatty acids (FA) toward adipose tissue through differential modulation of lipoprotein lipase (LPL) activity. Each complex correlated inversely with high density lipoprotein cholesterol (HDL) in control subjects. We thus investigated ANGPTL3/8 and ANGPTL4/8 levels in type 2 diabetes patients, who can present with decreased HDL. While ANGPTL3/8 levels in type 2 diabetes patients were similar to those previously observed in normal controls, ANGPTL4/8 levels were roughly twice as high as those in control subjects. Concentrations of ANGPTL3/8 and ANGPTL4/8 in type 2 diabetes patients were inversely correlated with HDL, with the correlation being significant for ANGPTL4/8. We therefore measured the ability of the various ANGPTL proteins and complexes to inhibit endothelial lipase (EL), the enzyme which hydrolyzes phospholipids (PL) in HDL. While confirming ANGPTL3 as an EL inhibitor, we found that ANGPTL4 was a more potent EL inhibitor than ANGPTL3. Interestingly, we observed that while ANGPTL3/8 had increased EL-inhibitory activity compared to ANGPTL3 alone, ANGPTL4/8 exhibited decreased potency in inhibiting EL compared to ANGPTL4 alone. Together, these results show for the first time that ANGPTL4 is a more potent EL inhibitor than ANGPTL3 and suggest a possible reason for why ANGPTL4/8 levels are correlated inversely with HDL. Elsevier 2021-08-30 /pmc/articles/PMC8417300/ /pubmed/34504977 http://dx.doi.org/10.1016/j.heliyon.2021.e07898 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Article Chen, Yan Q. Pottanat, Thomas G. Siegel, Robert W. Ehsani, Mariam Qian, Yue-Wei Konrad, Robert J. Angiopoietin-like protein 4 (ANGPTL4) is an inhibitor of endothelial lipase (EL) while the ANGPTL4/8 complex has reduced EL-inhibitory activity |
title | Angiopoietin-like protein 4 (ANGPTL4) is an inhibitor of endothelial lipase (EL) while the ANGPTL4/8 complex has reduced EL-inhibitory activity |
title_full | Angiopoietin-like protein 4 (ANGPTL4) is an inhibitor of endothelial lipase (EL) while the ANGPTL4/8 complex has reduced EL-inhibitory activity |
title_fullStr | Angiopoietin-like protein 4 (ANGPTL4) is an inhibitor of endothelial lipase (EL) while the ANGPTL4/8 complex has reduced EL-inhibitory activity |
title_full_unstemmed | Angiopoietin-like protein 4 (ANGPTL4) is an inhibitor of endothelial lipase (EL) while the ANGPTL4/8 complex has reduced EL-inhibitory activity |
title_short | Angiopoietin-like protein 4 (ANGPTL4) is an inhibitor of endothelial lipase (EL) while the ANGPTL4/8 complex has reduced EL-inhibitory activity |
title_sort | angiopoietin-like protein 4 (angptl4) is an inhibitor of endothelial lipase (el) while the angptl4/8 complex has reduced el-inhibitory activity |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417300/ https://www.ncbi.nlm.nih.gov/pubmed/34504977 http://dx.doi.org/10.1016/j.heliyon.2021.e07898 |
work_keys_str_mv | AT chenyanq angiopoietinlikeprotein4angptl4isaninhibitorofendotheliallipaseelwhiletheangptl48complexhasreducedelinhibitoryactivity AT pottanatthomasg angiopoietinlikeprotein4angptl4isaninhibitorofendotheliallipaseelwhiletheangptl48complexhasreducedelinhibitoryactivity AT siegelrobertw angiopoietinlikeprotein4angptl4isaninhibitorofendotheliallipaseelwhiletheangptl48complexhasreducedelinhibitoryactivity AT ehsanimariam angiopoietinlikeprotein4angptl4isaninhibitorofendotheliallipaseelwhiletheangptl48complexhasreducedelinhibitoryactivity AT qianyuewei angiopoietinlikeprotein4angptl4isaninhibitorofendotheliallipaseelwhiletheangptl48complexhasreducedelinhibitoryactivity AT konradrobertj angiopoietinlikeprotein4angptl4isaninhibitorofendotheliallipaseelwhiletheangptl48complexhasreducedelinhibitoryactivity |